🚀 VC round data is live in beta, check it out!
Center Laboratories Valuation Multiples
Discover revenue and EBITDA valuation multiples for Center Laboratories and similar public comparables like Alto Neuroscience, Omeros, Janux Therapeutics, Biotest and more.
Center Laboratories Overview
About Center Laboratories
Center Laboratories Inc is active in the healthcare sector. The company is engaged in the manufacture and sale of various Western medicines. The segments include: Pharmaceutical Division which includes manufacturing and sales of various Western Medicines; Biotechnology Venture Capital consists Investing in domestic and foreign biotechnology undertakings; Glac segment - Manufacture and sale of probiotic products and others. It geographically operates in Taiwan, China and Others.
Founded
1957
HQ
Employees
200
Website
Sectors
Financials (FY)
EV
$1B
Center Laboratories Financials
Center Laboratories reported last fiscal year revenue of $48M and EBITDA of $379M.
In the same fiscal year, Center Laboratories generated $20M in gross profit, $379M in EBITDA, and $295M in net income.
Center Laboratories P&L
In the most recent fiscal year, Center Laboratories reported revenue of $48M and EBITDA of $379M.
Center Laboratories expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $48M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $20M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 41% | XXX | XXX | XXX |
| EBITDA | — | XXX | $379M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 788% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (24%) | XXX | XXX | XXX |
| Net Profit | — | XXX | $295M | XXX | XXX | XXX |
| Net Margin | — | XXX | 615% | XXX | XXX | XXX |
| Net Debt | — | — | $141M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Center Laboratories Stock Performance
Center Laboratories has current market cap of $971M, and enterprise value of $1B.
Market Cap Evolution
Center Laboratories' stock price is $1.28.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $971M | -2.9% | XXX | XXX | XXX | $0.39 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCenter Laboratories Valuation Multiples
Center Laboratories trades at 22.7x EV/Revenue multiple, and 2.9x EV/EBITDA.
Center Laboratories Financial Valuation Multiples
As of April 18, 2026, Center Laboratories has market cap of $971M and EV of $1B.
Equity research analysts estimate Center Laboratories' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Center Laboratories has a P/E ratio of 3.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $971M | XXX | $971M | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 22.7x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 2.9x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (94.9x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 55.3x | XXX | XXX | XXX |
| P/E | — | XXX | 3.3x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (189.8x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Center Laboratories Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Center Laboratories Margins & Growth Rates
Center Laboratories' revenue in the last fiscal year declined by (6%).
Center Laboratories' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Center Laboratories Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (6%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 788% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (1629%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 16% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 14% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 65% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Center Laboratories Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Center Laboratories | XXX | XXX | XXX | XXX | XXX | XXX |
| Alto Neuroscience | XXX | XXX | XXX | XXX | XXX | XXX |
| Omeros | XXX | XXX | XXX | XXX | XXX | XXX |
| Janux Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Biotest | XXX | XXX | XXX | XXX | XXX | XXX |
| PeptiDream | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Center Laboratories M&A Activity
Center Laboratories acquired XXX companies to date.
Last acquisition by Center Laboratories was on XXXXXXXX, XXXXX. Center Laboratories acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Center Laboratories
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCenter Laboratories Investment Activity
Center Laboratories invested in XXX companies to date.
Center Laboratories made its latest investment on XXXXXXXX, XXXXX. Center Laboratories invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Center Laboratories
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Center Laboratories
| When was Center Laboratories founded? | Center Laboratories was founded in 1957. |
| Where is Center Laboratories headquartered? | Center Laboratories is headquartered in Taiwan. |
| How many employees does Center Laboratories have? | As of today, Center Laboratories has over 200 employees. |
| Is Center Laboratories publicly listed? | Yes, Center Laboratories is a public company listed on Taipei Exchange. |
| What is the stock symbol of Center Laboratories? | Center Laboratories trades under 4123 ticker. |
| When did Center Laboratories go public? | Center Laboratories went public in 2003. |
| Who are competitors of Center Laboratories? | Center Laboratories main competitors are Alto Neuroscience, Omeros, Janux Therapeutics, Biotest. |
| What is the current market cap of Center Laboratories? | Center Laboratories' current market cap is $971M. |
| What is the current revenue of Center Laboratories? | Center Laboratories' last fiscal year revenue is $48M. |
| What is the current EV/Revenue multiple of Center Laboratories? | Current revenue multiple of Center Laboratories is 22.7x. |
| Is Center Laboratories profitable? | No, Center Laboratories is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.